Medicure MCUJF
OTC MCUJF
$2.93 -0.05 (-1.68%)
At close: Oct 15, 2026 · 4:00 PM EDT

Medicure (MCUJF) EBIT Margin (2009 - 2026)

Updated

Medicure (MCUJF) reported EBIT Margin of -18.22% for the quarter ended Jun 30, 2026, down 7.74 percentage points from -10.48% a year earlier and down 87.20 percentage points from the prior quarter.

Analysis

Medicure (MCUJF) EBIT Margin (2009 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Medicure's EBIT Margin came in at 50.18%, up 21.02 percentage points year-over-year; for the year ended Dec 31, 2025, it came in at 4.46%, down 18.86 percentage points from the prior year.

  • EBIT Margin has declined for three consecutive years, though with a five-year change of +74.28 percentage points (years ended Dec 2020 to Dec 2025).
  • By year, EBIT Margin came in at 23.32% in the year ended Dec 31, 2024 (-2.88 pp), 26.20% in the year ended Dec 31, 2023 (-9.10 pp), 35.29% in the year ended Dec 31, 2022 (+44.92 pp) and -9.63% in the year ended Dec 31, 2021 (+60.20 pp).
  • The figure for the quarter ended Jun 30, 2026 ranks as the lowest quarterly EBIT Margin since the quarter ended Jun 30, 2024.
  • Year over year, EBIT Margin gained in four of the last eight quarters, with an average year-over-year change of +8.14 percentage points.
  • The high point for year-over-year EBIT Margin in five years was the quarter ended Sep 30, 2022 (a gain of 120.47 percentage points); the low point was the quarter ended Sep 30, 2023 (a drop of 103.91 percentage points).
  • Per Business Quant data, the three quarters before the quarter ended Jun 30, 2026 came in at 68.98% (quarter ended Mar 31, 2026), 81.92% (quarter ended Dec 31, 2025) and 60.94% (quarter ended Sep 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Eli Lilly 1,130.22 Bn 1,098.81 Bn 19.71 Bn 51.16%
2 Johnson & Johnson 613.62 Bn 532.15 Bn 17.26 Bn 28.21%
3 AbbVie 501.46 Bn 474.57 Bn 12.70 Bn 37.86%
4 Merck 366.84 Bn 321.22 Bn 12.21 Bn -3.52%
5 Novartis Ag 297.85 Bn 261.84 Bn 11.24 Bn 32.97%
6 Astrazeneca 261.66 Bn 235.34 Bn 12.86 Bn 20.57%
7 Amgen 235.39 Bn 190.79 Bn 7.24 Bn 34.95%
8 Gilead Sciences 190.66 Bn 164.86 Bn 6.22 Bn -133.21%
9 Pfizer 169.57 Bn 116.22 Bn 10.94 Bn 28.37%
10 Medicure 30.58 Mn 22.42 Mn 2.31 Mn -18.22%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -18.22%
Mar 31, 2026 20.06%
Dec 31, 2025 0.90%
Sep 30, 2025 10.90%
Jun 30, 2025 -10.48%
Mar 31, 2025 -11.94%
Dec 31, 2024 -8.48%
Sep 30, 2024 -22.45%
Jun 30, 2024 -21.65%
Mar 31, 2024 0.67%
Dec 31, 2023 -31.49%
Sep 30, 2023 1.82%
Jun 30, 2023 5.46%
Mar 31, 2023 92.89%
Dec 31, 2022 85.73%
Sep 30, 2022 16.11%
Mar 31, 2022 41.43%
Sep 30, 2021 -14.74%
Jun 30, 2021 -15.18%
Mar 31, 2021 37.34%
API Access

Medicure EBIT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit-margin&ticker=MCUJF&period=max&api_key=YOUR_API_KEY